Clinical Trial Update: Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation [Phase 3]

View source ↗

Summary

A Phase 3 trial by AstraZeneca evaluated the efficacy and safety of a treatment for opioid-induced constipation in patients with non-cancer-related pain. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Snippet

Sponsor: AstraZeneca | Conditions: Opioid-Induced Constipation (OIC) | Phase 3 | Status: COMPLETED | Results posted: 2015-06-02